Every three minutes, someone in the UK is diagnosed with dementia. It is not an easy diagnosis to receive for the patient or ...
Alzheimer’s disease has long resisted simple solutions, but a new line of research suggests an unexpected pairing could help keep the condition at bay: a marijuana-derived compound working alongside a ...
Find out about the innovations in dementia treatment, particularly new therapies that target Alzheimer's disease and improve quality of life.
NEW YORK (AP) _ Shares of Axovant Sciences nearly doubled in value after the dementia drug developer said its initial public offering raised $315 million, more than Axovant had expected. The offering ...
Researchers have developed smart nanoparticles that can seek out and destroy disease-causing proteins the body can’t normally eliminate. Unlike traditional drugs, these particles can reach ...
Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...
Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...
Conventional treatments of Alzheimer's disease, one of the most common forms of dementia, have been largely focused on ...
China's medicine regulator has ordered a halt to the import, sale and usage of a drug used to treat dementia associated with Alzheimer's disease made by India's Sun Pharmaceutical Industries , ...
A new genetic study suggests that obesity and high blood pressure may play a direct role in causing dementia, not just increasing the risk. By analyzing data from large populations in Denmark and the ...
Scientists have developed a new nanoparticle-based strategy that could dramatically expand the range of disease-causing proteins that can be targeted by modern medicine. A newly released perspective i ...
Prioritizing nonpharmacologic strategies, enhancing staff training, and distinguishing Delirium Superimposed on Dementia (DSD) are vital to improving outcomes for hospitalized patients with Alzheimer ...